Biocure Technology Inc.

Biocure Technology Inc.verified

CURE.CN

Price:

$0.005

Market Cap:

$525.01K

Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It also engages in the research and development of CAR T Cell therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and ha...[Read more]

Industry

Biotechnology

IPO Date

2009-02-16

Stock Exchange

CNQ

Ticker

CURE.CN

The PE Ratio as of December 2025 (TTM) for Biocure Technology Inc. (CURE.CN) is 0.17

According to Biocure Technology Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.17. This represents a change of -100.03% compared to the average of -499.06 of the last 4 quarters.

Biocure Technology Inc. (CURE.CN) Historical PE Ratio (quarterly & annually)

How has CURE.CN PE Ratio performed in the past?

The mean historical PE Ratio of Biocure Technology Inc. over the last ten years is -16500.69. The current 0.17 PE Ratio has changed -100.10% with respect to the historical average. Over the past ten years (40 quarters), CURE.CN's PE Ratio was at its highest in in the December 2021 quarter at 9.72. The PE Ratio was at its lowest in in the March 2017 quarter at -299700.00.

Quarterly (TTM)
Annual

Average

-16500.69

Median

-67.65

Minimum

-164435.33

Maximum

-13.50

Biocure Technology Inc. (CURE.CN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Biocure Technology Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 7.44%

Maximum Annual PE Ratio = -13.50

Minimum Annual Increase = -99.94%

Minimum Annual PE Ratio = -164435.33

Quarterly (TTM)
Annual
YearPE RatioChange
2024-36.05-31.70%
2023-52.78291.09%
2022-13.50-87.35%
2021-106.6670.73%
2020-62.4743.55%
2019-43.52-40.25%
2018-72.84-6.41%
2017-77.83-26.50%
2016-105.90-99.94%
2015-164435.337.44%

Biocure Technology Inc. (CURE.CN) Average PE Ratio

How has CURE.CN PE Ratio performed in the past?

The current PE Ratio of Biocure Technology Inc. (CURE.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-34.11

5-year avg

-54.29

10-year avg

-16500.69

Biocure Technology Inc. (CURE.CN) PE Ratio vs. Peers

How is CURE.CN’s PE Ratio compared to its peers?

Biocure Technology Inc.’s PE Ratio is greater than Bioasis Technologies Inc. (-0.12), greater than ChitogenX Inc. (-0.44), greater than Albert Labs International Corp. (-0.04), less than WPD Pharmaceuticals Inc. (283.88), greater than Nirvana Life Sciences Inc. (-801.87), greater than Jack Nathan Medical Corp. (-0.21), greater than Aquarius Surgical Technologies Inc. (-1.18), greater than Xebra Brands Ltd. (-0.41), less than NanoSphere Health Sciences Inc. (0.73), greater than Global Hemp Group Inc. (-0.14),

Build a custom stock screener for Biocure Technology Inc. (CURE.CN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocure Technology Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biocure Technology Inc. (CURE.CN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biocure Technology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Biocure Technology Inc.'s PE Ratio?

How is the PE Ratio calculated for Biocure Technology Inc. (CURE.CN)?

What is the highest PE Ratio for Biocure Technology Inc. (CURE.CN)?

What is the 3-year average PE Ratio for Biocure Technology Inc. (CURE.CN)?

What is the 5-year average PE Ratio for Biocure Technology Inc. (CURE.CN)?

How does the current PE Ratio for Biocure Technology Inc. (CURE.CN) compare to its historical average?